JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 55 filers reported holding JANUX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,498,193 | +5.0% | 942,281 | +23.7% | 0.00% | – |
| Q2 2023 | $9,044,820 | -3.3% | 761,990 | -1.4% | 0.00% | – |
| Q1 2023 | $9,349,125 | -5.9% | 772,655 | +2.4% | 0.00% | – |
| Q4 2022 | $9,938,345 | -3.5% | 754,620 | -0.8% | 0.00% | – |
| Q3 2022 | $10,297,000 | +29.8% | 760,474 | +17.1% | 0.00% | – |
| Q2 2022 | $7,932,000 | -2.3% | 649,640 | +14.8% | 0.00% | – |
| Q1 2022 | $8,116,000 | -22.8% | 565,979 | +6.2% | 0.00% | – |
| Q4 2021 | $10,517,000 | -8.3% | 533,071 | +0.5% | 0.00% | – |
| Q3 2021 | $11,470,000 | +1486.4% | 530,242 | +1729.9% | 0.00% | – |
| Q2 2021 | $723,000 | – | 28,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |